198 related articles for article (PubMed ID: 12629510)
1. Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration.
Liu JW; Shen JJ; Tanzillo-Swarts A; Bhatia B; Maldonado CM; Person MD; Lau SS; Tang DG
Oncogene; 2003 Mar; 22(10):1475-85. PubMed ID: 12629510
[TBL] [Abstract][Full Text] [Related]
2. Expression of biomarkers modulating prostate cancer angiogenesis: differential expression of annexin II in prostate carcinomas from India and USA.
Banerjee AG; Liu J; Yuan Y; Gopalakrishnan VK; Johansson SL; Dinda AK; Gupta NP; Trevino L; Vishwanatha JK
Mol Cancer; 2003 Oct; 2():34. PubMed ID: 14613585
[TBL] [Abstract][Full Text] [Related]
3. The impact of altered annexin I protein levels on apoptosis and signal transduction pathways in prostate cancer cells.
Hsiang CH; Tunoda T; Whang YE; Tyson DR; Ornstein DK
Prostate; 2006 Sep; 66(13):1413-24. PubMed ID: 16741918
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression.
Sharma MR; Koltowski L; Ownbey RT; Tuszynski GP; Sharma MC
Exp Mol Pathol; 2006 Oct; 81(2):146-56. PubMed ID: 16643892
[TBL] [Abstract][Full Text] [Related]
5. Loss of annexin II heavy and light chains in prostate cancer and its precursors.
Chetcuti A; Margan SH; Russell P; Mann S; Millar DS; Clark SJ; Rogers J; Handelsman DJ; Dong Q
Cancer Res; 2001 Sep; 61(17):6331-4. PubMed ID: 11522620
[TBL] [Abstract][Full Text] [Related]
6. PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progression.
Xu LL; Shi Y; Petrovics G; Sun C; Makarem M; Zhang W; Sesterhenn IA; McLeod DG; Sun L; Moul JW; Srivastava S
Cancer Res; 2003 Aug; 63(15):4299-304. PubMed ID: 12907594
[TBL] [Abstract][Full Text] [Related]
7. Expression and functional role of CCR9 in prostate cancer cell migration and invasion.
Singh S; Singh UP; Stiles JK; Grizzle WE; Lillard JW
Clin Cancer Res; 2004 Dec; 10(24):8743-50. PubMed ID: 15623660
[TBL] [Abstract][Full Text] [Related]
8. Annexin 2 expression is reduced in human osteosarcoma metastases.
Gillette JM; Chan DC; Nielsen-Preiss SM
J Cell Biochem; 2004 Jul; 92(4):820-32. PubMed ID: 15211578
[TBL] [Abstract][Full Text] [Related]
9. The 44 kDa Pim-1 kinase directly interacts with tyrosine kinase Etk/BMX and protects human prostate cancer cells from apoptosis induced by chemotherapeutic drugs.
Xie Y; Xu K; Dai B; Guo Z; Jiang T; Chen H; Qiu Y
Oncogene; 2006 Jan; 25(1):70-8. PubMed ID: 16186805
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of human colon adenocarcinoma cells alters the expression and intracellular localization of annexins A1, A2, and A5.
Guzmán-Aránguez A; Olmo N; Turnay J; Lecona E; Pérez-Ramos P; López de Silanes I; Lizarbe MA
J Cell Biochem; 2005 Jan; 94(1):178-93. PubMed ID: 15526283
[TBL] [Abstract][Full Text] [Related]
11. Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells.
Song J; Aumüller G; Xiao F; Wilhelm B; Albrecht M
Prostate; 2004 Mar; 58(4):394-405. PubMed ID: 14968440
[TBL] [Abstract][Full Text] [Related]
12. Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression.
Grzmil M; Hemmerlein B; Thelen P; Schweyer S; Burfeind P
J Pathol; 2004 Jan; 202(1):50-9. PubMed ID: 14694521
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation.
Sharma M; Ownbey RT; Sharma MC
Exp Mol Pathol; 2010 Apr; 88(2):278-86. PubMed ID: 20079732
[TBL] [Abstract][Full Text] [Related]
14. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
Das S; Roth CP; Wasson LM; Vishwanatha JK
Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178
[TBL] [Abstract][Full Text] [Related]
15. EPLIN, epithelial protein lost in neoplasm.
Maul RS; Chang DD
Oncogene; 1999 Dec; 18(54):7838-41. PubMed ID: 10618726
[TBL] [Abstract][Full Text] [Related]
16. Tenascin C and annexin II expression in the process of pancreatic carcinogenesis.
Esposito I; Penzel R; Chaib-Harrireche M; Barcena U; Bergmann F; Riedl S; Kayed H; Giese N; Kleeff J; Friess H; Schirmacher P
J Pathol; 2006 Apr; 208(5):673-85. PubMed ID: 16450333
[TBL] [Abstract][Full Text] [Related]
17. Retinol metabolism and lecithin:retinol acyltransferase levels are reduced in cultured human prostate cancer cells and tissue specimens.
Guo X; Knudsen BS; Peehl DM; Ruiz A; Bok D; Rando RR; Rhim JS; Nanus DM; Gudas LJ
Cancer Res; 2002 Mar; 62(6):1654-61. PubMed ID: 11912136
[TBL] [Abstract][Full Text] [Related]
18. Intracellular clusterin induces G2-M phase arrest and cell death in PC-3 prostate cancer cells1.
Scaltriti M; Santamaria A; Paciucci R; Bettuzzi S
Cancer Res; 2004 Sep; 64(17):6174-82. PubMed ID: 15342402
[TBL] [Abstract][Full Text] [Related]
19. Nuclear annexin II negatively regulates growth of LNCaP cells and substitution of ser 11 and 25 to glu prevents nucleo-cytoplasmic shuttling of annexin II.
Liu J; Rothermund CA; Ayala-Sanmartin J; Vishwanatha JK
BMC Biochem; 2003 Sep; 4():10. PubMed ID: 12962548
[TBL] [Abstract][Full Text] [Related]
20. Non-redundant inhibitor of differentiation (Id) gene expression and function in human prostate epithelial cells.
Asirvatham AJ; Schmidt MA; Chaudhary J
Prostate; 2006 Jun; 66(9):921-35. PubMed ID: 16541417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]